Pancreatic tumors with combined exocrine and endocrine features
Ryo Harada, Akihiro Takiyama, Maki Kaneko(Children's Hospital of Los Angeles), Hiroyuki Maguchi(Teine Keijinkai Hospital), Manabu Osanai, Akio Katanuma(Tokyo Medical and Dental University), Kei Yane(Teine Keijinkai Hospital), Toshiya Shinohara(Hokkaido University), Shin Kato(National Agriculture and Food Research Organization), Kuniyuki Takahashi(Teine Keijinkai Hospital), Ryusuke Katoh, Syunpei Hashigo, Yoshiyasu Ambo(Hokkaido University of Science)
Cited by 2
Related Papers
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial
|Annals of Oncology|2019|333
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315
Forty Consecutive Resections of Hilar Cholangiocarcinoma With No Postoperative Mortality and No Positive Ductal Margins
|Annals of Surgery|2004|276
Evidence-based clinical practice guidelines for cholelithiasis 2016
|Journal of Gastroenterology|2016|262